Education
About Us
Working with TipRanks
Follow Us
Envista Holdings Corp (NVST)
NYSE:NVST
NVST Stock Chart & Stats
$29.10
-$0.72(-3.69%)
At close: 4:00 PM EST
$29.10
-$0.72(-3.69%)
Day’s Range― - ―
52-Week Range$14.22 - $29.28
Previous CloseN/A
Volume757.64K
Average Volume (3M)2.82M
Market Cap
$4.78B
Enterprise Value$5.17B
Total Cash (Recent Filing)$1.13B
Total Debt (Recent Filing)$1.60B
Price to Earnings (P/E)105.9
Beta0.91
Next Earnings
May 06, 2026EPS Estimate
0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.38
Shares Outstanding164,426,240
10 Day Avg. Volume4,372,365
30 Day Avg. Volume2,823,853
Financial Highlights & Ratios
PEG Ratio-0.74
Price to Book (P/B)1.17
Price to Sales (P/S)1.34
P/FCF Ratio15.83
Enterprise Value/Market Cap1.08
Enterprise Value/Revenue1.97
Enterprise Value/Gross Profit3.56
Enterprise Value/Ebitda15.12
Forecast
1Y Price Target
$27.42Price Target Upside-5.77% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering14
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Multi-segment GrowthAnalyst highlights above-market growth driven by implants, clear aligners, and diagnostic equipment, indicating broad-based revenue expansion and market share gains.
Pricing And Margin ImprovementAnalyst cites price increases and cost reductions in key product lines as tailwinds that support margin improvement even if pricing pressure eases.
Product Pipeline And CommercializationAnalyst emphasizes that recent product launches materially contributed to revenue and that a pipeline of further launches should support continued sales and cross-selling opportunities.
Bears Say
Macroeconomic HeadwindsAnalyst warns that weak consumer spending and higher borrowing costs could reduce patient demand for elective procedures and constrain revenue growth.
One-time Drivers Of Reported ResultsAnalyst cautions that deferred partner orders and one-time compensation effects boosted reported results, creating uncertainty about the sustainability of recent performance.
Valuation And Upside LimitationsAnalyst observes that the share price appears to reflect much of the company improvement and that a valuation premium limits meaningful upside, supporting a cautious rating.
Envista Holdings News
NVST FAQ
What was Envista Holdings Corp’s price range in the past 12 months?
Envista Holdings Corp lowest stock price was $14.22 and its highest was $29.27 in the past 12 months.
What is Envista Holdings Corp’s market cap?
Envista Holdings Corp’s market cap is $4.78B.
When is Envista Holdings Corp’s upcoming earnings report date?
Envista Holdings Corp’s upcoming earnings report date is May 06, 2026 which is in 85 days.
How were Envista Holdings Corp’s earnings last quarter?
Envista Holdings Corp released its earnings results on Feb 05, 2026. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.323 by $0.057.
Is Envista Holdings Corp overvalued?
According to Wall Street analysts Envista Holdings Corp’s price is currently Overvalued.
Does Envista Holdings Corp pay dividends?
Envista Holdings Corp does not currently pay dividends.
What is Envista Holdings Corp’s EPS estimate?
Envista Holdings Corp’s EPS estimate is 0.31.
How many shares outstanding does Envista Holdings Corp have?
Envista Holdings Corp has 164,426,240 shares outstanding.
What happened to Envista Holdings Corp’s price movement after its last earnings report?
Envista Holdings Corp reported an EPS of $0.38 in its last earnings report, beating expectations of $0.323. Following the earnings report the stock price went up 17.766%.
Which hedge fund is a major shareholder of Envista Holdings Corp?
Currently, no hedge funds are holding shares in NVST
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Envista Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$27.42 (-5.77% Downside)
$27.42 (-5.77% Downside)
Blogger Sentiment
Bullish
NVST Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 1.5M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 13.8%
Last 30 Days ▲ 19.9%
Last 30 Days ▲ 19.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
33.54%
12-Months-Change
Fundamentals
Return on Equity
1.56%
Trailing 12-Months
Asset Growth
4.19%
Trailing 12-Months
Company Description
Envista Holdings Corp
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
NVST Company Deck
NVST Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong operational and financial progress: broad-based revenue growth, notable margin and EPS expansion, high free cash flow conversion, product innovation momentum, cost reduction in G&A, and a return to shareholder-friendly actions (repurchases). Notable risks include FX comparability effects, tariff headwinds (~$30M in 2025; ~$40M annualized in 2026), China VBP timing uncertainty, some segment margin pressure (Diagnostics/Equipment) and the fact that portions of Q4 growth were aided by non-recurring items. On balance, the company presented measurable, repeatable improvements and conservative guidance that account for known risks while projecting continued progress in 2026.View all NVST earnings summariesNVST Revenue Breakdown
63.99% Specialty Products & Technologies
36.01% Equipment & Consumables
NVST Stock 12 Month Forecast
Average Price Target
$27.42
▼(-5.77% Downside)
Technical Analysis
DENTSPLY SIRONA
―
Disc Medicine
―
Clover Health Investments
―
AbCellera Biologics
―
Bausch + Lomb Corporation
―
Ownership Overview
Currently, No data available
---